Reductions in albuminuria with SGLT2 inhibitors: a marker for improved renal outcomes in patients without diabetes?

The Lancet Diabetes & Endocrinology(2020)

引用 8|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要